CanSino Biologics Inc.

CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for its efforts in developing the adenovirus-based viral vector vaccine and other biologics that address significant medical needs. CanSino Biologics covers a wide range of therapeutic areas, including infectious diseases, cancer, and more, using cutting-edge technology and scientific innovation to enhance preventative healthcare. The company has a prominent role within the pharmaceutical industry, contributing to both domestic and international public health initiatives. CanSino Biologics' products are pivotal in controlling outbreaks and have positioned the company as a significant player in the global vaccine market by providing solutions against various diseases, supporting both community health and preparedness for emerging health threats.